In Investing

First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

Author

We appreciate you signing up! You’re now part of our community and will be the first to receive our latest updates, exclusive offers, and special content. Stay tuned for exciting news and insights straight to your inbox.
Your name

Your email
By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Popular News
- In Investing
  SOURCE ROCK ROYALTIES ANNOUNCES FOURTH QUARTER & YEAR-END 2024 RESULTS INCLUDING RECORD ANNUAL FUNDS FROM OPERATIONS
  April 28, 2025 No Comments
- In Investing
  Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
  April 28, 2025 No Comments

SOURCE ROCK ROYALTIES ANNOUNCES FOURTH QUARTER & YEAR-END 2024 RESULTS INCLUDING RECORD ANNUAL FUNDS FROM OPERATIONS